Predicting Adverse Drug Events Using Pharmacological Network Models
- 21 December 2011
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (114), 114ra127
- https://doi.org/10.1126/scitranslmed.3002774
Abstract
Early and accurate identification of adverse drug events (ADEs) is critically important for public health. We have developed a novel approach for predicting ADEs, called predictive pharmacosafety networks (PPNs). PPNs integrate the network structure formed by known drug-ADE relationships with information on specific drugs and adverse events to predict likely unknown ADEs. Rather than waiting for sufficient post-market evidence to accumulate for a given ADE, this predictive approach relies on leveraging existing, contextual drug safety information, thereby having the potential to identify certain ADEs earlier. We constructed a network representation of drug-ADE associations for 809 drugs and 852 ADEs on the basis of a snapshot of a widely used drug safety database from 2005 and supplemented these data with additional pharmacological information. We trained a logistic regression model to predict unknown drug-ADE associations that were not listed in the 2005 snapshot. We evaluated the model’s performance by comparing these predictions with the new drug-ADE associations that appeared in a 2010 snapshot of the same drug safety database. The proposed model achieved an AUROC (area under the receiver operating characteristic curve) statistic of 0.87, with a sensitivity of 0.42 given a specificity of 0.95. These findings suggest that predictive network methods can be useful for predicting unknown ADEs.Keywords
This publication has 39 references indexed in Scilit:
- Role of systems pharmacology in understanding drug adverse eventsWires Systems Biology and Medicine, 2010
- EIDOSDrug Safety, 2010
- Predicting new molecular targets for known drugsNature, 2009
- Network analyses in systems pharmacologyBioinformatics, 2009
- Data-Driven Methods to Discover Molecular Determinants of Serious Adverse Drug EventsClinical Pharmacology & Therapeutics, 2009
- The Knowledge-Integrated Network Biomarkers Discovery for Major Adverse Cardiac EventsJournal of Proteome Research, 2008
- Drug Target Identification Using Side-Effect SimilarityScience, 2008
- Prediction of drug–target interaction networks from the integration of chemical and genomic spacesBioinformatics, 2008
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profilingBritish Journal of Pharmacology, 2007
- Pharma's year of trouble and strifeNature Reviews Drug Discovery, 2006